NeuroscienceNature CommunicationsPeer-reviewed
Development of an RNA Aptamer as a Therapeutic Agent for Synucleinopathies
Kazuma Murakami, Thi Hong Van Nguyen, Leo Tsuda…·Gal Bitan
This paper develops an RNA aptamer, 1R6, that targets synuclein and shows therapeutic potential in synucleinopathies by inhibiting aggregation and promoting disaggregation.
DOI 10.1038/s41467-026-75209-z